Exodus Point Capital Management, LP Repligen Corp Transaction History

Exodus Point Capital Management, LP

  • $14.6 Billion
  • Q4 2024

A detailed history of Exodus Point Capital Management, LP transactions in Repligen Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 213,718 shares of RGEN stock, worth $33.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
213,718
Previous 95,931 122.78%
Holding current value
$33.5 Million
Previous $14.3 Million 115.49%
% of portfolio
0.21%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$123.41 - $160.92 $14.5 Million - $19 Million
117,787 Added 122.78%
213,718 $30.8 Million
Q3 2024

Nov 12, 2024
BUY
$119.79 - $167.35 $7.8 Million - $10.9 Million
65,138 Added 211.54%
95,931 $14.3 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $3.7 Million - $5.63 Million
30,793 New
30,793 $3.88 Million
Q2 2023

Aug 10, 2023
SELL
$138.42 - $180.31 $3.69 Million - $4.8 Million
-26,635 Reduced 68.43%
12,287 $1.74 Million
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $4.66 Million - $5.99 Million
30,220 Added 347.28%
38,922 $6.55 Million
Q4 2022

Feb 13, 2023
SELL
$162.42 - $220.56 $6.38 Million - $8.67 Million
-39,300 Reduced 81.87%
8,702 $1.47 Million
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $4.67 Million - $7.46 Million
29,133 Added 154.4%
48,002 $8.98 Million
Q2 2022

Aug 19, 2022
BUY
$140.68 - $188.02 $2.65 Million - $3.55 Million
18,869 New
18,869 $3.06 Million
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $7.71 Million - $12.3 Million
-47,805 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$247.59 - $304.47 $15.3 Million - $18.9 Million
-61,985 Reduced 56.46%
47,805 $12.7 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $21.4 Million - $35.6 Million
109,790 New
109,790 $31.7 Million
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $1.8 Million - $2.4 Million
-10,880 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$180.37 - $226.26 $1.14 Million - $1.43 Million
6,315 Added 138.34%
10,880 $2.12 Million
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $267,876 - $373,685
1,809 Added 65.64%
4,565 $875,000
Q3 2020

Nov 16, 2020
SELL
$122.51 - $158.27 $5.5 Million - $7.1 Million
-44,865 Reduced 94.21%
2,756 $407,000
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $4.49 Million - $6.69 Million
47,621 New
47,621 $5.89 Million
Q4 2019

Feb 14, 2020
SELL
$73.84 - $93.08 $545,677 - $687,861
-7,390 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $270,421 - $336,959
3,528 Added 91.35%
7,390 $567,000
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $209,320 - $331,938
3,862 New
3,862 $332,000

Others Institutions Holding RGEN

# of Institutions
482
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.69B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email